The Impact of Medical Comorbidities on Cough Improvement Following Superior Laryngeal Block

CONCLUSION: Underlying lung pathology may contribute to decreased iSLN blockade efficacy in the treatment of chronic refractory cough from laryngeal hypersensitivity and its treatment is likely necessary for optimal symptom reduction. Characterizing patient comorbidity profiles can help guide patient counseling on expected treatment efficacy.PMID:38375777 | DOI:10.1177/00034894241231375
Source: The Annals of Otology, Rhinology, and Laryngology - Category: ENT & OMF Authors: Source Type: research